IGM Biosciences Stock Quote IGMS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

12.30

Bid

12.00

Ask

12.42

Volume

152,567

11.1801 Day's Range 12.50

3.81 52 Week Range 76.20

Market Cap

729.62M

Previous Close

11.39

Open

11.44

Last Trade

12.25

Last Trade Time

Financial Volume

$ 1,786,134

VWAP

11.7072

Average Volume (3m)

294,789

Shares Outstanding

59,318,669

Dividend Yield

PE Ratio

-2.96

Earnings Per Share (EPS)

-4.15

Revenue

2.13M

Net Profit

-246.42M

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.igmbio.com

Headquarters

Dover, Delaware, USA

Founded

IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IGMS. The last closing price for IGM Biosciences was $11.39. Over the last year, IGM Biosciences shares have traded in a share price range of $ 3.81 to $ 76.20.

IGM Biosciences currently has 59,318,669 shares outstanding. The market capitalization of IGM Biosciences is $675.64 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -2.96.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.04	32.8293736501	9.26	12.5	8.81	158420	10.36556858	CS
4	5.59	83.3084947839	6.71	14.38	6.1721	268707	9.70708925	CS
12	2.3	23	10	14.38	6.1721	294789	9.3828502	CS
26	4.74	62.6984126984	7.56	17.7	3.81	307868	8.87464905	CS
52	-60.21	-83.0368225072	72.51	76.2	3.81	347596	18.95560845	CS
156	-6.01	-32.8235936647	18.31	133	3.81	274428	30.5660416	CS
260	0	0	0	12.5	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NOVVUNova Vision Acquisition Corporation	$ 41.00 (207.35%)	17.4k
NOVVNova Vision Acquisition Corporation	$ 37.0001 (200.08%)	205.22k
SMXSMX Security Matters Public Company	$ 5.85 (138.78%)	50.1M
OMICSingular Genomics Systems Inc	$ 12.38 (119.12%)	2.87M
TILInstill Bio Inc	$ 84.75 (82.41%)	3.91M
GSIWGarden Stage Ltd	$ 2.9693 (-75.66%)	4.24M
UPCUniverse Pharmaceuticals Inc	$ 0.55 (-67.07%)	30.45M
VMARVision Marine Technologies Inc	$ 0.77 (-48.67%)	34.54M
PRLDPrelude Therapeutics Inc	$ 2.775 (-42.55%)	2.49M
CNEYCN Energy Group Inc	$ 0.4335 (-37.17%)	5.06M
NVDANVIDIA Corporation	$ 119.10 (-0.03%)	238.43M
XXII22nd Century Group Inc	$ 0.3447 (28.00%)	183.73M
IMRXImmuneering Corporation	$ 2.02 (41.26%)	136.36M
SQQQProShares UltraPro Short QQQ	$ 8.17 (-1.33%)	127.78M
MULNMullen Automotive Inc	$ 0.1328 (-20.48%)	120.81M